Meds & supplements › Apixaban
Medicine · Factor Xa Inhibitor
Apixaban is a factor Xa inhibitor
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
WARNING: (A) PREMATURE DISCONTINUATION OF APIXABAN INCREASES THE RISK OF THROMBOTIC EVENTS (B) SPINAL/EPIDURAL HEMATOMA (A) PREMATURE DISCONTINUATION OF APIXABAN INCREASES THE RISK OF THROMBOTIC EVENTS Premature discontinuation of any oral anticoagulant, including apixaban, increases the risk of thrombotic events. If anticoagulation with apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant. (B) SPINAL/EPIDURAL HEMATOMA Epidural or spinal hematomas may occur in patients treated with apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: • use of indwelling epidural catheters • concomitant use of other drugs that affect hemostasis, such as nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants • a history of traumatic or repeated epidural or spinal punctures • a history of spinal deformity or spinal surgery • optimal timing between the administration of apixaban and neuraxial procedures is not known Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary. Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated. WARNING: (A) PREMATURE DISCONTINUATION OF APIXABAN INCREASES THE RISK OF THROMBOTIC EVENTS (B) SPINAL/EPIDURAL HEMATOMA See full prescribing information for complete boxed warning. (A) PREMATURE DISCONTINUATION OF APIXABAN INCREASES THE RISK OF THROMBOTIC EVENTS: Premature discontinuation of any oral anticoagulant, including apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
Apixaban tablets are a prescription medicine used to:
It is not known if apixaban tablets are safe and effective in children.
People with atrial fibrillation (a type of irregular heartbeat) are at an increased risk of forming a blood clot in the heart, which can travel to the brain, causing a stroke, or to other parts of the body. Apixaban lowers your chance of having a stroke by helping to prevent clots from forming. If you stop taking apixaban, you may have increased risk of forming a clot in your blood.
Do not stop taking apixaban tablets without talking to the doctor who prescribes it for you. Stopping apixaban increases your risk of having a stroke.
Apixaban tablets may need to be stopped, if possible, prior to surgery or a medical or dental procedure. Ask the doctor who prescribed apixaban tablets for you when you should stop taking it. Your doctor will tell you when you may start taking apixaban tablets again after your surgery or procedure. If you have to stop taking apixaban tablets, your doctor may prescribe another medicine to help prevent a blood clot from forming.
You may have a higher risk of bleeding if you take apixaban tablets and take other medicines that increase your risk of bleeding, including:
Tell your doctor if you take any of these medicines. Ask your doctor or pharmacist if you are not sure if your medicine is one listed above.
While taking apixaban tablets:
Call your doctor or get medical help right away if you have any of these signs or symptoms of bleeding when taking apixaban tablets:
If you take apixaban tablets and receive spinal anesthesia or have a spinal puncture, your doctor should watch you closely for symptoms of spinal or epidural blood clots or bleeding. Tell your doctor right away if you have tingling, numbness, or muscle weakness, especially in your legs and feet.
Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all of the possible side effects of apixaban tablets. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Do not take apixaban tablets if you:
Before you take apixaban tablets, tell your doctor if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some of your other medicines may affect the way apixaban tablets works. Certain medicines may increase your risk of bleeding or stroke when taken with apixaban tablets.
Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.
Store apixaban tablets at room temperature between 68°F to 77°F (20°C to 25°C). Keep apixaban tablets and all medicines out of the reach of children. General Information about apixaban tablets Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use apixaban tablets for a condition for which it was not prescribed. Do not give apixaban tablets to other people, even if they have the same symptoms that you have. It may harm them.
If you would like more information, talk with your doctor. You can ask your pharmacist or doctor for information about apixaban tablets that is written for health professionals.
sofidex [Internet]. Daloreum; c2026. Apixaban; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/apixaban
sofidex. (2026, August 2). Apixaban. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/apixaban
Apixaban. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/apixaban
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.